UBS Group’s Akso Health Group AHG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43K | Buy |
+963
| New | +$1.74K | ﹤0.01% | 9554 |
|
|
2025
Q4 | – | Sell |
-13,032
| Closed | -$22.5K | – | 10450 |
|
|
2025
Q3 | $22.5K | Buy |
13,032
+70
| +0.5% | +$121 | ﹤0.01% | 8077 |
|
|
2025
Q2 | $16.9K | Buy |
12,962
+5,320
| +70% | +$7.13K | ﹤0.01% | 8549 |
|
|
2025
Q1 | $8.79K | Buy |
7,642
+1,368
| +22% | +$1.8K | ﹤0.01% | 8724 |
|
|
2024
Q4 | $8.53K | Buy |
6,274
+4,356
| +227% | +$4.38K | ﹤0.01% | 8406 |
|
|
2024
Q3 | $2.05K | Sell |
1,918
-16,429
| -90% | -$16.6K | ﹤0.01% | 8509 |
|
|
2024
Q2 | $15K | Buy |
18,347
+17,115
| +1,389% | +$15.5K | ﹤0.01% | 7486 |
|
|
2024
Q1 | $1.43K | Buy |
+1,232
| New | +$1.7K | ﹤0.01% | 8137 |
|
|
2023
Q2 | – | Sell |
-2,104
| Closed | -$747 | – | 8840 |
|
|
2023
Q1 | $747 | Sell |
2,104
-5,263
| -71% | -$2.16K | ﹤0.01% | 8917 |
|
|
2022
Q4 | $2.8K | Buy |
7,367
+670
| +10% | +$342 | ﹤0.01% | 9624 |
|
|
2022
Q3 | $6K | Buy |
+6,697
| New | +$7.11K | ﹤0.01% | 8992 |
|
|
2022
Q1 | – | Sell |
-5,431
| Closed | -$9K | – | 10180 |
|
|
2021
Q4 | $9K | Buy |
5,431
+5,391
| +13,478% | +$20K | ﹤0.01% | 8880 |
|
|
2021
Q3 | $0 | Buy |
+40
| New | +$67 | ﹤0.01% | 9476 |
|
|
2021
Q2 | – | Sell |
-2,458
| Closed | -$4K | – | 9345 |
|
|
2021
Q1 | $4K | Buy |
+2,458
| New | +$5.55K | ﹤0.01% | 8405 |
|
|
2020
Q4 | – | Sell |
-1,704
| Closed | -$3K | – | 8351 |
|
|
2020
Q3 | $3K | Buy |
1,704
+1,139
| +202% | +$2.54K | ﹤0.01% | 7506 |
|
|
2020
Q2 | $1K | Buy |
+565
| New | +$997 | ﹤0.01% | 7732 |
|
|
2020
Q1 | – | Sell |
-8,068
| Closed | -$23K | – | 7919 |
|
|
2019
Q4 | $23K | Buy |
8,068
+7,245
| +880% | +$19K | ﹤0.01% | 6785 |
|
|
2019
Q3 | $4K | Buy |
+823
| New | +$5.16K | ﹤0.01% | 7529 |
|
|
2019
Q1 | – | Sell |
-2,581
| Closed | -$19K | – | 7687 |
|
|
2018
Q4 | $19K | Buy |
2,581
+1,830
| +244% | +$30.1K | ﹤0.01% | 6817 |
|
|
2018
Q3 | $18K | Sell |
751
-1,207
| -62% | -$31.3K | ﹤0.01% | 6854 |
|
|
2018
Q2 | $59K | Buy |
+1,958
| New | +$66.6K | ﹤0.01% | 5851 |
|
Other funds holding AHG
SP
HNB
CIAM
UBS Group's AHG Position: Q2 2026 in Review
UBS Group opened a new position in Akso Health Group (AHG) in Q2 2026: 963 shares worth $1.43K. The stake represents ﹤0.01% of the portfolio and ranks #9554 among its holdings. This is a return to the name: UBS Group previously reported a position in AHG as recently as Q3 2025.
UBS Group first reported a position in AHG in Q2 2018 and has held it in 21 quarters since. The position peaked at $59K in Q2 2018. 9 funds tracked by Wall St. Rank hold AHG as of Q2 2026.
- UBS Group held 963 shares of Akso Health Group worth $1.43K as of Q2 2026.
- Akso Health Group was a new UBS Group position in Q2 2026.
- Akso Health Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9554 holding.
- UBS Group first reported a position in Akso Health Group in Q2 2018 and has held it in 21 quarters since.
- UBS Group's Akso Health Group position peaked at $59K in Q2 2018.
- 9 funds tracked by Wall St. Rank held Akso Health Group as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.